Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Vivaldi Biosciences

Vivaldi Biosciences is a biotechnology company developing live attenuated influenza vaccines founded in 2010 by Adolfo García-Sastre, Peter Palese and Elliott Kieff.

Overview Structured Data Issues Contributors Activity

vivaldibiosciences.com

Is a

Company

Organization

Company attributes

Industry

Healthcare

Vaccine

Biomedical engineering

Technology

Biology

Biotechnology

...

Location

New York City

Colorado

‌

Fort Collins, Colorado

B2X

CEO

Founder

AngelList URL

angel.co/vivaldi-biosciences

Pitchbook URL

pitchbook.com/profiles.../53791-93

Legal Name

Vivaldi Biosciences, Inc.

Number of Employees (Ranges)

11 – 500

Email Address

info@vivaldibiosciences.com0

Full Address

Mariahilferstrasse 101/1/21 1060 Wien, Austria0

3185-A Rampart Road, Fort Collins, Colorado 80523, US

Investors

NGN Capital

Founded Date

2010

Total Funding Amount (USD)

2,000,000

Latest Funding Round Date

May 18, 2007

Business Model

Commerce

Latest Funding Type

Wellfound ID

Country

Other attributes

Company Operating Status

Active

Public/Private

Private0

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Vivaldi Biosciences

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Access by API

By using this site, you agree to our Terms of Service.